Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Sun Pharmaceutical Industries Ltd. Share Price
Day's Range
Day's Range
Low
₹1,880.30
High
₹1,916.60
Price Summary
| Previous Close | ₹1,883.30 |
|---|---|
| Day's Range | ₹1,880.30 - ₹1,916.60 |
| Open | ₹1,900.50 |
| 52 Week Range | ₹1,548.00 - ₹1,911.00 |
| Volume | 20,21,838 |
| Market Cap | ₹0.46 |
| Previous Close | ₹1,884.95 |
|---|---|
| Day's Range | ₹1,880.00 - ₹1,917.15 |
| Open | ₹1,906.00 |
| 52 Week Range | ₹1,547.25 - ₹1,911.95 |
| Volume | 51,424 |
| Market Cap | ₹0.46 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 38,077.28 |
|---|---|
| Market Cap (₹ in Mn) | 0.46 |
| Dividend Yield(%) | 0.84 |
| Price/Earning (TTM) | 41.88 |
| TTM EPS (₹) | 45.49 |
| P/E Ratio | 38.10 |
| Book Value(₹) | 5.63 |
| PAT Margin (%) | 20.88 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 19.89 |
| Trade Value ( ₹ in Lacs) | 969.32 |
|---|---|
| Market Cap (₹ in Mn) | 0.46 |
| Dividend Yield(%) | 0.84 |
| Price/Earning (TTM) | 41.88 |
| TTM EPS (₹) | 45.49 |
| P/E Ratio | 38.10 |
| Book Value(₹) | 5.63 |
| PAT Margin (%) | 20.88 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 19.89 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 136754.6 | 202751.7 |
| Expenses | N/A | N/A |
| PBT | 34718.4 | 34496.5 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 29129.8 | 28581.8 |
About Sun Pharmaceutical Industries Ltd.
| Founded | 1993 |
|---|---|
| Managing Director | Kirti Ganorkar |
| NSE Symbol | SUNPHARMA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,57,121.30 | 1,884.95 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,81,396.01 | 6,899.10 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,729.85 | 4,454.60 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,15,331.11 | 8,034.15 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,240.83 | 1,409.50 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,126.23 | 1,336.50 | 1,148.40 - 1,148.40 |
| Mankind Pharma Ltd. | 1,03,056.40 | 2,489.00 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,03,022.72 | 1,066.65 | 903.00 - 903.00 |
| Lupin Ltd. | 1,03,010.73 | 2,291.60 | 1,836.80 - 1,836.80 |
| Zydus Lifesciences Ltd. | 99,737.91 | 1,017.45 | 835.50 - 835.50 |
No Records Found
Latest News
Sun Pharmaceutical Industries informs about investor presentation
Sun Pharmaceutical Industries informs about press release
Sun Pharmaceutical Industries informs about press release
Sun Pharmaceutical Industries informs about completion and results of postal ballot
Sun Pharmaceutical Industries has informed that the postal ballot process initiated pursuant to the notice dated 17 March 2026, wherein the voting period commenced on 19 March 2026, has been concluded today, 17 April 2026. Based on the Scrutinizer’s Report, the following resolutions as set out in the Postal Ballot Notice dated 17 March 2026 have been duly passed by the shareholders with the requisite majority and shall be deemed passed on 17 April 2026 to take effect in accordance with applicable regulatory requirements and subject to completion of statutory filings and compliance. Ratification of the remuneration of the Cost Auditor for FY 2025–26; Alteration to Clause III(A) (Main Objects) of the Memorandum of Association; and 3. Re-appointment of Dr Pawan Goenka as an Independent Director for a second term of five years, effective from 21 May 2026. The Voting Results have been filed by the Company in XBRL mode, and the Scrutinizer Report is made available on the Company’s website at www.sunpharma.com.
Sun Pharmaceutical Industries informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Sun Pharmaceutical Industries Ltd. is ₹1,883.30 as of 2026-05-19.
The market capitalisation of Sun Pharmaceutical Industries Ltd. is ₹457,121.30 as of 2026-05-18.
The 1-year return of Sun Pharmaceutical Industries Ltd. is -22.50% as of 2026-05-19.
The P/E ratio of Sun Pharmaceutical Industries Ltd. is 38.10 as of 2026-05-19.
The 52-week high and low of Sun Pharmaceutical Industries Ltd. are ₹1,911.00 and ₹1,548.00, respectively, as of 2026-05-19.
People Also Ask
Sun Pharmaceutical Industries Ltd. offers more than 2,000 molecules across generics, branded generics, specialty medicines, OTC and APIs, covering key therapy areas such as cardiology, psychiatry, neurology, dermatology, oncology, ophthalmology and diabetes care in over 100 countries.
Sun Pharmaceutical Industries Ltd. expands access to medicines through licensing agreements for key molecules in areas like HIV, COVID-19 and dermatology, working with partners such as Merck, Philogen, Aclaris and China Medical System to reach hospital and public-sector patients.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
